Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2013

Mar 6, 2013

31982_dirs_2013-03-06_9fed3703-f36d-4962-a3fa-b96de5741165.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2013-03-02

Reporting Person: DOUGLAS RICHARD (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-03-02 Options-right to buy $1.83 A 30000 Acquired 2023-03-01 Common Stock (30000) Direct

Footnotes

F1: Options vest 6 months from the date of grant.